Staveley-O'Carroll KF

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Staveley-O'Carroll

Contact Staveley-O'Carroll, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen

Jul 02, 2023 |

By Lin KY, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI

| ncbi.nlm.nih.gov

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Open in Who Shared View Duplicates (555)

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Staveley-O'Carroll

Contact Staveley-O'Carroll, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Overview

Use Cases

Capabilities

Industries

Library

Commmunity

Customers

Staveley-O'Carroll KF

Get in touch with Staveley-O'Carroll

Actions

Is this you?

Articles

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen

Actions

Is this you?

Get in touch with Staveley-O'Carroll